The fact that breast cancer development in BRCA1-mutation carriers is crucially affected by female sex hormones led to the question whether RANK/RANKL, which are key molecules in the mammary gland downstream of steroid hormones, have a role in the aetiology of BRCA1 mutation-driven breast cancer. This evidence concerns the gene BRCA1 and breast carcinoma.